Amneal Pharmaceuticals says it is “working aggressively to expand sales” through new launches and remains “hyper focused” on introducing new products to the market. With approximately 250 generic products currently marketed, the company has 95 products awaiting US Food and Drug Administration approval, along with 94 products in development.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?